secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mereo BioPharma Group plc (MREO)
CIK:        0001719714
Form:       8-K
Filed at:   2026-05-14T14:22:48+00:00
Accession:  0001193125-26-223071
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mereo BioPharma shareholders approve all 11 resolutions at 2026 AGM
-------------------------------------------------------------------

- 436,766,255 ordinary shares represented at the May 14, 2026 AGM.
- Directors Justin Roberts, Dr. Daniel Shames, and Marc Yoskowitz re-elected with >93% support each.
- Directors' remuneration policy approved with 91.74% of votes for.
- Authorization to allot shares up to £3,591,354.73 passed with 80.54% for, valid until June 30, 2029.
- All resolutions including auditor reappointment and advisory say-on-pay passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719714/000119312526223071/0001193125-26-223071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719714/000119312526223071/mreo-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-223071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer